Applications of Gene Therapy - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 316

[225] Rade JJ, Schulick AH, Virmani R, Dichek DA. Local adenoviral mediated expression
of recombinant hirudin reduces neointima formation after arterial injury. Nat Med
1996;2:293-8.
[226] Waugh JM, Kattash M, Li J, Yuksel E, Kuo MD, Lussier M, et al. Gene therapy to pro-
mote thromboresistance: local overexpression of tissue plasminogen activator to prevent
arterial thrombosis in an in vivo rabbit model. Proc Natl Acad Sci USA 1999;96:1065-70.
[227] Nishida T, Ueno H, Atsuchi N, Kawano R, Asada Y, Nakahara Y, et al.
Adenovirusmediated local expression of human tissue factor pathway inhibitor elimi-
nates shear stress-induced recurrent thrombosis in the injured carotid artery of the rab-
bit. Circ Res 1999;84:1446-52.
[228] Zoldhelyi P, McNatt J, Shelat HS, Yamamoto Y, Chen ZQ, Willerson JT.
Thromboresistance of balloon injured porcine carotid arteries after local gene transfer
of human tissue factor pathway inhibitor. Circulation 2000;101:289-95.
[229] Waugh JM, Yuksel E, Li J, Kuo MD, Kattash M, Saxena R, et al. Local overexpression
of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ
Res 1999;84:84-92.
[230] Zoldhelyi P, McNatt J, Xu XM, Mitchell DL, Meidell RS, Clubb Jr FJ, et al. Prevention
of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene.
Circulation 1996;93:10-17.
[231] Bonaros N, Bernecker O, Ott H, Schlechta B, Kocher AA. Cell and gene therapy for
ischemic heart disease. Minerva Cardioangiol 2005;53:265-73.
[232] Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, et al. Direct intra-
muscular gene transfer of naked DNA encoding vascular endothelial growth factor aug-
ments collateral development and tissue perfusion. Circulation 1996;94:3281-90.
[233] Mack CA, Patel SR, Schwarz EA, Zanzonico P, Hahn RT, Ilercil A, et al. Biologic
bypass with the use of adenovirus-mediated gene transfer of the complementary deoxy-
ribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfu-
sion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998;115:
168-77.
[234] Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, et al. Therapeutic
angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments
revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93:662-70.
[235] Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz. M, Biro S, et al.
Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by
vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9.
[236] Gowdak LH, Poliakova L, Wang X, Kovesdi I, Fishbein KW, Zacheo A, et al.
Adenovirusmediated VEGF121 gene transfer stimulates angiogenesis in normoperfused
skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation
2000;102:565-71.
[237] Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG. Adenovirus-mediated gene
transfer of VEGF121 improves lower-extremity endothelial function and flow reserve.
Circulation 2001;104:753-5.
[238] Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, et al.
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration
of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically sig-
nificant severe coronary artery disease. Circulation 1999;100:468-74.
[239] Giordano FJ, Ping P, McKirnan MD, Nozaki S, DeMaria AN, et al. Intracoronary gene
transfer of fibroblast growth factor-5 increases blood flow and contractile function in an
ischemic region of the heart. Nat Med 1996;2:534-9.